We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO IP Counsels Committee ConferenceApril 8-10, 2019
BIO International ConventionJune 3-6, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
Genome editing is a process by which a strand of DNA is modified to produce a desired outcome.
The history of selecting animals such as cows, chickens, and pigs with improved genetics has provided steady improvement to their sustainability, welfare and disease resistance.
The history of selecting plants with improved genetics has provided steady improvements including increased yields while using fewer resources and greater resistance to disease and pests.
Plant and animal breeding are continually improving as people learn more about biology. Gene editing is really just the newest tool in a very long history of biological advancement.
The genome is comprised of DNA and functions as the “instruction book” of a cell. Genes are specific strands of DNA which provide the cell instructions for making different proteins.
This FAQ document focuses on the utilization of genome editing in humans to treat disease.
In February 2017, BIO and NAS co-hosted a webinar on breakthroughs and next steps in human genome editing.